ANI Pharmaceuticals, Inc. (ANIP)
78.32
-1.82
(-2.27%)
USD |
NASDAQ |
Apr 10, 15:59
78.32
0.00 (0.00%)
After-Hours: 20:00
ANI Pharmaceuticals Shareholders Equity (Quarterly) : 540.72M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Liquidia Corp. | 44.75M |
| Catalyst Pharmaceuticals, Inc. | 954.27M |
| Indivior Pharmaceuticals, Inc. | -98.00M |
| Replimune Group, Inc. | 210.54M |
| ADMA Biologics, Inc. | 477.32M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.440B |
| Total Liabilities (Quarterly) | 899.65M |
| Debt to Equity Ratio | 1.162 |
| Current Ratio | 2.707 |
| Net Debt Paydown Yield | 0.25% |